Total planned funding: $513,922,159
Clear active filters
Management Sciences for Health
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Ethiopia | $93,862,193 |
Nigeria | $92,548,034 |
Haiti | $47,500,295 |
Kenya | $42,415,778 |
South Africa | $39,376,955 |
Uganda | $39,175,221 |
Vietnam | $27,614,449 |
Namibia | $22,447,388 |
Rwanda | $21,359,613 |
Tanzania | $16,783,164 |
Lesotho | $11,434,378 |
Eswatini | $10,457,526 |
Malawi | $10,343,544 |
Democratic Republic of the Congo | $5,063,500 |
Ukraine | $4,735,330 |
Guyana | $4,683,290 |
Dominican Republic | $3,878,863 |
Cameroon | $3,793,635 |
Mozambique | $3,333,132 |
Angola | $2,808,000 |
South Sudan | $2,414,000 |
Botswana | $2,374,270 |
Central America Region | $2,040,000 |
Côte d'Ivoire | $1,900,000 |
enumerations.Philippines | $500,000 |
India | $500,000 |
China | $300,111 |
Burundi | $250,000 |
Ghana | $29,490 |
Zimbabwe | $0 |
Central Asia Region | $0 |
Organizational Types
NGO | $494,793,859 |
Implementing Agency | $16,492,300 |
Unknown | $2,636,000 |
Program Areas
Treatment | $171,837,953 |
Governance and Systems | $161,081,996 |
Care | $80,477,666 |
Prevention | $63,372,888 |
Testing | $18,680,090 |
Budget Codes
OHSS: Health Systems Strengthening | $117,049,229 |
HTXS: Treatment: Adult Treatment | $98,211,812 |
HTXD: Treatment: ARV Drugs | $60,983,530 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $32,448,112 |
HLAB: Laboratory Infrastructure | $30,429,173 |
HBHC: Care: Adult Care and Support | $30,307,553 |
HVTB: Care: TB/HIV | $23,242,001 |
HKID: Care: Orphans and Vulnerable Children | $22,657,316 |
HVCT: Testing: HIV Testing and Counseling | $18,680,090 |
HVSI: Strategic Information | $13,603,594 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $13,530,689 |
PDTX: Treatment: Pediatric Treatment | $12,642,611 |
HVOP: Sexual Prevention: Other Sexual Prevention | $11,635,805 |
PDCS: Care: Pediatric Care and Support | $4,270,796 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,350,000 |
HMIN: Biomedical Prevention: Injection Safety | $1,862,394 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $1,193,320 |
HMBL: Biomedical Prevention: Blood Safety | $352,568 |